Table 4.
Adverse events that needed medical treatment or resulted in long-term sequelae.
| Symptoms (Total = 190) | Number of experienced respondents (n (%)) | Time to resolution (weeks) | Outcome (%) | |||
|---|---|---|---|---|---|---|
| Cured | Unresolved | |||||
| Outpatient | Hospitalized | Transferred | ||||
| (multiple choice) | ||||||
| Dimple | 76 (30.5) | 4.8 ± 4.46 | 75.0 | 0.0 | 19.7 | 5.3 |
| Fever/inflammation | 72 (28.9) | 1.9 ± 0.98 | 51.4 | 1.4 | 45.8 | 1.4 |
| Exposure of thread | 70 (28.1) | 2.0 ± 1.24 | 95.7 | 1.4 | 1.4 | 1.4 |
| Pain in treatment area | 62 (24.9) | 1.6 ± 1.10 | 91.9 | 1.6 | 6.5 | 0.0 |
| Hematoma | 61 (24.5) | 2.6 ± 1.19 | 77.0 | 1.6 | 21.3 | 0.0 |
| Hyperplasia, nodules and sclerotic skin | 40 (16.1) | 7.3 ± 7.48 | 32.5 | 5.0 | 50.0 | 12.5 |
| Nerve damage | 31 (12.4) | 7.6 ± 5.03 | 32.3 | 9.7 | 35.5 | 22.6 |
| Salivary gland damage | 8 (3.2) | 3.8 ± 3.35 | 12.5 | 0.0 | 50.0 | 37.5 |
| Hypersensitivity | 1 (0.4) | 2.0 ± 4.99 | 0.0 | 0.0 | 100.0 | 0.0 |